More Globe Newswire

View Older Stories View Newer Stories

Feb 24, 2026 07:00AM OROCO COMMENCES PHASE 2 DRILLING
Feb 24, 2026 07:00AM Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
Feb 24, 2026 07:00AM Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 24, 2026 07:00AM Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates
Feb 24, 2026 07:00AM Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
Feb 24, 2026 07:00AM Shoals Technologies Group and ON.energy to Deploy Critical-Power Systems for Leading AI Data-Center Operator
Feb 24, 2026 07:00AM Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
Feb 24, 2026 07:00AM Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
Feb 24, 2026 07:00AM iBio to Participate in Upcoming Investor Conferences
Feb 24, 2026 07:00AM Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
Feb 24, 2026 07:00AM Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026
Feb 24, 2026 07:00AM Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Feb 24, 2026 07:00AM Abaxx Exchange Completes First Physical Delivery Under Gold Singapore Futures Contract
Feb 24, 2026 07:00AM OTC Markets Group Welcomes GR Silver Mining Ltd. to OTCQX
Feb 24, 2026 07:00AM OTC Markets Group Welcomes Dryden Gold Corp. to OTCQX
Feb 24, 2026 07:00AM Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052
Feb 24, 2026 07:00AM Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
Feb 24, 2026 07:00AM Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
Feb 24, 2026 07:00AM Avalo Therapeutics to Participate in Upcoming Investor Conferences
Feb 24, 2026 07:00AM OTC Markets Group Welcomes Nations Royalty Corp. to OTCQX
Feb 24, 2026 07:00AM Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2025
Feb 24, 2026 07:00AM Autolus Therapeutics to Participate in Upcoming Investor Conferences
Feb 24, 2026 07:00AM Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
Feb 24, 2026 07:00AM AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
Feb 24, 2026 07:00AM Indivior to Participate in Upcoming Investor Conferences
Feb 24, 2026 07:00AM Full year Trading Update and Notice of Results
Feb 24, 2026 06:59AM OR Royalties Announces Acquisition of Additional Royalties on Spring Valley in Nevada
Feb 24, 2026 06:58AM Amendment of the Liquidity Agreement with Kepler Cheuvreux
Feb 24, 2026 06:56AM Form 8.3 - Picton Property Income Limited
Feb 24, 2026 06:55AM YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
Feb 24, 2026 06:54AM Form 8.3 - LondonMetric Property Plc
Feb 24, 2026 06:50AM Form 8.3 - Bluefield Solar Income Fund Ltd
Feb 24, 2026 06:50AM Dillard’s, Inc. Reports Fourth Quarter and Fiscal Year Results
Feb 24, 2026 06:50AM ANI Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 24, 2026 06:45AM Global Indemnity Group 2025 Earnings Release & Conference Call
Feb 24, 2026 06:45AM Global Indemnity Group 2025 Earnings Release & Conference Call
Feb 24, 2026 06:45AM BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026
Feb 24, 2026 06:45AM Ring Energy Announces Timing of Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
Feb 24, 2026 06:31AM CECO Environmental Reports Fourth Quarter and Full Year 2025 Results
Feb 24, 2026 06:30AM Palvella Therapeutics Announces Positive Topline Results from Phase 3 SELVA Clinical Study of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations
Feb 24, 2026 06:30AM CECO Environmental Announces Strategic Combination with Thermon Group, Creating a Global Industrial Leader in Delivering Mission-Critical Environmental and Thermal Solutions
Feb 24, 2026 06:30AM Bimergen Advances Redbird 100 MW / 400 MWh Texas Battery Project with JDA Acceptance and Selection of Eos Z3™ Technology
Feb 24, 2026 06:24AM Goliath Reports Numerous High-Grade Intercepts Including 24.16 g/t AuEq Over 7.00 Meters, Grade Values Increased By 19.6 % In 56 Gold Equivalent Drill Results, And Expands Vast Stacked Vein System At
Feb 24, 2026 06:17AM HSBC Continental Europe: Pre Stabilisation Notice
Feb 24, 2026 06:15AM Form 8.3 - [IDOX PLC - 23 02 2026] - (CGWL)
Feb 24, 2026 06:15AM Pelican Acquisition Corporation and Greenland Energy Announce SEC Effectiveness of Registration Statement
Feb 24, 2026 06:09AM Reporting of granting of Tryg shares by senior management
Feb 24, 2026 06:08AM Acquisition of ISS A/S shares by Members of the Board of Directors
Feb 24, 2026 06:08AM Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
Feb 24, 2026 06:07AM Looper Robotics Redefines Physical AI Infrastructure with Global Debut of Insight9 Spatial AI Camera
View Newer Stories View Older Stories